These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28747426)

  • 1. Intestinal epithelial cell endoplasmic reticulum stress promotes MULT1 up-regulation and NKG2D-mediated inflammation.
    Hosomi S; Grootjans J; Tschurtschenthaler M; Krupka N; Matute JD; Flak MB; Martinez-Naves E; Gomez Del Moral M; Glickman JN; Ohira M; Lanier LL; Kaser A; Blumberg R
    J Exp Med; 2017 Oct; 214(10):2985-2997. PubMed ID: 28747426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.
    Stengel ST; Fazio A; Lipinski S; Jahn MT; Aden K; Ito G; Wottawa F; Kuiper JWP; Coleman OI; Tran F; Bordoni D; Bernardes JP; Jentzsch M; Luzius A; Bierwirth S; Messner B; Henning A; Welz L; Kakavand N; Falk-Paulsen M; Imm S; Hinrichsen F; Zilbauer M; Schreiber S; Kaser A; Blumberg R; Haller D; Rosenstiel P
    Gastroenterology; 2020 Oct; 159(4):1357-1374.e10. PubMed ID: 32673694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paneth cells as a site of origin for intestinal inflammation.
    Adolph TE; Tomczak MF; Niederreiter L; Ko HJ; Böck J; Martinez-Naves E; Glickman JN; Tschurtschenthaler M; Hartwig J; Hosomi S; Flak MB; Cusick JL; Kohno K; Iwawaki T; Billmann-Born S; Raine T; Bharti R; Lucius R; Kweon MN; Marciniak SJ; Choi A; Hagen SJ; Schreiber S; Rosenstiel P; Kaser A; Blumberg RS
    Nature; 2013 Nov; 503(7475):272-6. PubMed ID: 24089213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H; Kim J; Cosman D; Choi I
    Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.
    Carayannopoulos LN; Naidenko OV; Fremont DH; Yokoyama WM
    J Immunol; 2002 Oct; 169(8):4079-83. PubMed ID: 12370332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
    Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
    J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1.
    Hosomi S; Grootjans J; Huang YH; Kaser A; Blumberg RS
    Front Immunol; 2018; 9():1324. PubMed ID: 29973929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis.
    Welz L; Kakavand N; Hang X; Laue G; Ito G; Silva MG; Plattner C; Mishra N; Tengen F; Ogris C; Jesinghaus M; Wottawa F; Arnold P; Kaikkonen L; Stengel S; Tran F; Das S; Kaser A; Trajanoski Z; Blumberg R; Roecken C; Saur D; Tschurtschenthaler M; Schreiber S; Rosenstiel P; Aden K
    Gastroenterology; 2022 Jan; 162(1):223-237.e11. PubMed ID: 34599932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
    Wittenbrink M; Spreu J; Steinle A
    Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
    Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
    Schrama D; Terheyden P; Otto K; Kämmerer U; Bröcker EB; Lühder F; Cosman D; Andersen MH; Becker JC
    Eur J Immunol; 2006 Jan; 36(1):65-72. PubMed ID: 16342232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.
    Nice TJ; Coscoy L; Raulet DH
    J Exp Med; 2009 Feb; 206(2):287-98. PubMed ID: 19171762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
    Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A
    Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4.
    Zöller T; Wittenbrink M; Hoffmeister M; Steinle A
    Front Immunol; 2018; 9():620. PubMed ID: 29651291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
    Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
    Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UL16 binding proteins.
    Cao W; He W
    Immunobiology; 2004; 209(3):283-90. PubMed ID: 15518340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity.
    Nielsen MM; Dyring-Andersen B; Schmidt JD; Witherden D; Lovato P; Woetmann A; Ødum N; Poulsen SS; Havran WL; Geisler C; Bonefeld CM
    J Invest Dermatol; 2015 May; 135(5):1311-1319. PubMed ID: 25634359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
    Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.